Owner Stem Cell Sciences Holdings Limited

Convention GB 13 January 2006 2411072A

Service Shelston IP

Various Convention priority claimed: 13 January 2006, United Kingdom, No. 2411072A in respect of CLASS:.* Provisions of subsection 41(5) applied.

Filing Date 13 July 2006

Class 1 Reagents for use in biological processing (other than for medical or veterinary purposes); biological preparations for use in cell cultures (other than medical); cultures of cell media (other than for medical or veterinary use); media for cell culture for use in non-medical research laboratories; media for cell culture for use in the biotechnological industry; sera for non-medical research purposes; antibodies for scientific use; antibodies for diagnostic use; reagents for test kits; biological reagents for use in enzyme linked immuno-sorbent assays; products containing antibodies for use in science; tissue culture reagents; cell culture reagents; biological test kits; cell culture media (other than for medical or veterinary use)

Class 5 Biological reagents; biological reagents for use in embryology; biological reagents for use in molecular biology; reagents for use in biological processing (for medical purposes); reagents for use in biological processing (for veterinary purposes); agents for activating cellular functions; biological preparations for use in cell cultures (medical); sera; sera for in vivo use; antibodies; antibodies for immunodiagnostic purposes; antibodies for immunoprophylatic purposes; antibodies for immunotherapeutic purposes; antibodies for in-vivo use in detecting diseases in livestock; immunological antibodies for medical use; cell culture media

Class 9 Laboratory apparatus; cell counting apparatus; cell culture apparatus; plasticware and glassware for cell culture; cell culture instruments; software; software relating to data management

Class 42 Laboratory services; cell separation services; cell separation technology services; stem cell research services; stem cell culture services; advisory services relating to scientific research; pharmaceutical research services; contract research services; laboratory services relating to the production of monoclonal antibodies